Advertisement
Beam Therapeutics Inc.

Beam Therapeutics Inc. (BEAM) Stock Overview

Explore Beam Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

BEAM●NASDAQ
HealthcareBiotechnology
$32.84
$3.29(11.13%)
U.S. Market opens in 16h 8m
Advertisement

Beam Therapeutics Inc. (BEAM)

Meyka AI Score

Z

Key Financials

Market Cap3.4B
P/E Ratio-46.35
EPS (TTM)$-0.49
ROE-0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$17.88
3 Months$20.04
1 Year Target$22.34

BEAM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Beam Therapeutics Inc. (BEAM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -46.35 and a market capitalization of 3.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
11.10%
5-Day Change
0.24%
1-Month Change
9.14%
3-Month Change
19.64%
6-Month Change
13.56%
Year-to-Date (YTD) Change
18.43%
1-Year Change
91.43%
3-Year Change
-3.27%
5-Year Change
-60.26%
All-Time (Max) Change
75.09%

Contact Information

https://www.beamtx.com
857 327 8775
238 Main Street, Cambridge, MA, 02142

Company Facts

393 Employees
IPO DateFeb 6, 2020
CountryUS
Actively Trading

Frequently Asked Questions